Company Performance: Samsung Biologics' financial results, including revenue, profit margins, and earnings per share, heavily influence its stock price.

Industry Trends: Developments in the biopharmaceutical industry, such as new drug approvals, technological advancements, and regulatory changes, impact investor sentiment towards Samsung Biologics.

Overall Market Conditions: Broad economic factors, including interest rates, inflation, and global economic growth, affect investor risk appetite and overall stock market performance, thereby influencing Samsung Biologics' stock price.

Investor Sentiment: News, rumors, and analyst ratings regarding Samsung Biologics can shift investor sentiment and trading activity, leading to price fluctuations.

Competition: The performance and strategies of competitors in the contract development and manufacturing organization (CDMO) space can impact Samsung Biologics' market share and stock valuation.

Regulatory Environment: Changes in regulations related to drug manufacturing, clinical trials, and intellectual property can significantly affect Samsung Biologics' operations and stock price.

Technological Advancements: Breakthroughs in biomanufacturing technologies can influence Samsung Biologics' competitive advantage and long-term growth prospects, thereby impacting its stock price.

Global Health Crises: Pandemics or other global health emergencies can significantly impact demand for biopharmaceutical products and services, affecting Samsung Biologics' revenue and stock price.

Key Partnerships and Contracts: Major deals and collaborations with pharmaceutical companies can boost investor confidence and drive up Samsung Biologics' stock price.

Exchange Rates: Fluctuations in the value of the Korean Won (KRW) relative to other currencies can affect Samsung Biologics' international competitiveness and profitability, thereby impacting its stock price.